led to the establishment of the current cryopreservation procedure.
Especially, the advent of the Cryotop ® (Kitazato Corporation, Fuji, Japan) method using a less toxic vitrification medium and providing the ultrarapid speed of cooling and warming has allowed the cryopreservation of human unfertilized oocytes that used to be associated with low post-thaw survival rates and low normal fertilization rates. Another reason for the increased number of frozen-thawed embryo transfers is a report saying that the elevation of the progesterone (P4) level on the day of the human chorionic gonadotropin (hCG) injection administered as a part of controlled ovary stimulation leads to decreased implantation rates with fresh embryo transfer. 7, 8 With these reports, there was an impetus to cryopreserve all embryos and transfer the thawed embryos after endometrial preparation/natural cycle in patients with high P4 levels at oocyte retrieval. The freeze-all modality has been reported to not only improve implantation rates but also prevent OHSS. [9] [10] [11] [12] Increasingly women of advanced maternal age have sought fertility treatment as a result of social changes, such as the tendencies to marry or have children later in life. Ovarian age is a major determinant of the oocyte reserve, which can be determined using AMH 13 and generally requires prolonged duration of stimulation. How to overcome these difficulties and lead women of advanced maternal age to pregnancy is a challenge for physicians.
Frozen-thawed embryo transfer may have numerous advantages;
however, there are as yet few IVF centers that apply the freeze-all strategy to all patients. This study analyzed P4 and estradiol (E2) levels per mature oocyte, frozen-thawed embryo survival rate, and pregnancy rates with fresh embryo transfer and frozen-thawed embryo transfer in patients treated at our IVF center by age category to demonstrate the benefits of the freeze-all strategy especially in patients of advanced maternal age.
| MATERIAL S AND ME THODS

| Patients
Post-thaw embryo survival rate was assessed in 294 cycles in which slow-frozen embryos were thawed and 12 195 cycles in which vitrified embryos were thawed between 2008 and 2016 at our IVF center, except for the following cycles: (a) cycles in which non-pronuclear embryos were thawed (cycles in which both pronuclear and blastocyst embryos were thawed were excluded from the study), (b) cycles in which embryos cryopreserved by other methods than slow freezing or vitrification, and (c) cycles in which embryos derived from delayed intracytoplasmic sperm injection (ICSI) were thawed.
P4 and E2 levels per mature oocyte by age category were as- 
| Controlled ovarian stimulation protocol
The gonadotropins used for controlled ovarian stimulation (COS)
were human menopausal gonadotropin (Ferring Pharmaceuticals, Tokyo, Japan or ASKA Pharmaceutical, Tokyo, Japan) or recombi- (a) serum E2 level on the day of hCG injection was ≤6000 pg/mL, (b) the serum P4 level on the day of hCG injection was ≤1.5 ng/mL, and (c) no signs of OHSS were noticed after oocyte retrieval.
| Embryo culture and cryopreservation
For fresh embryo transfer, the embryos were individually cultured in and Vitrification Kits VT101 and VT102 (Kitazato BioPharma) were used for vitrification.
| Day 3 embryo transfer
All frozen-thawed embryo transfers were performed in artificial hormone replacement cycles, according to the endometrial preparation protocol using transdermal estradiol (Estrana Pregnancy was determined by urinary hCG measurement and transvaginal ultrasound scan. When the urinary hCG level at 14 days after embryo transfer was ≥50 IU/mL, the pregnancy test was considered to be positive and 1 week later, transvaginal ultrasound scan was performed to confirm the presence of an intrauterine gestational sac.
| Hormone assays
During the ovary stimulation cycle, serum FSH, LH, and E2 levels
were measured in house, on several occasions including the day of hCG injection on which serum P4 level was additionally measured, using an electrochemiluminescence immunoassay (Cobas ® e 411 plus, Roche Diagnostics KK, Tokyo, Japan).
| RE SULTS
| Post-thaw embryo survival rates with slow freezing and vitrification
The and 2016 was 99.1%, which was significantly higher than that with slow freezing (P < 0.001, Table 1 ).
3.2 | Serum P4 and E2 levels on the day of hCG injection and fertilization rates by age category Serum P4 and E2 levels on the day of hCG injection were compared among different age categories in 9081 cycles after COS between 2008 and 2016. The comparisons between different age categories showed that the serum P4 and E2 levels per mature oocyte significantly increased with advancing age (all P < 0.001, except for the P4 level between age category of ≥40 and ≤42 and 43≥: P < 0.05). The fertilization rates in younger patients in age categories of ≤30 years and ≥31 and ≤35 years were significantly higher than those in older patients in age category of ≥36 and ≤39 years (P = 0.006 and 0.048, respectively) and in age category of ≥40 and ≤42 years (both P < 0.001, Table 2 ).
| Pregnancy rates with fresh embryo transfer and frozen-thawed embryo transfer by serum P4 level on the day of hCG injection
The pregnancy rate with fresh embryo transfer was 25.2% in patients with low P4 levels on the day of hCG injection, which declined with the increase in P4 level. On the other hand, the pregnancy rate with frozen-thawed embryo transfer was not affected by P4 level.
The comparisons of pregnancy rates with fresh embryo transfer and frozen-thawed embryo transfer between different serum P4 level groups showed that the pregnancy rates with frozen-thawed embryo transfer were significantly higher than those with fresh embryo transfer in patients with P4 levels of 1 ≦ P4 < 1.5 (P < 0.001) and 1.5 ≦ P4 < 2 (P = 0.016) on the day of hCG injection.
The comparisons of fertilization rates between different serum P4 level groups showed that there were no significant differences Table 3 ).
| Pregnancy rates with fresh embryo transfer and frozen-thawed embryo transfer by age category
Comparisons of pregnancy rates with fresh embryo transfer and frozen-thawed embryo transfer among different age categories showed that the pregnancy rate with frozen-thawed embryo transfer was higher than that with fresh embryo transfer in age categories of ≤30 years, ≥31 and ≤35 years, ≥36 and ≤39 years, and ≥40 and ≤42 years, and lower in an age category of ≥43 years. The statistically significant difference between pregnancy rates with fresh embryo transfer and frozen-thawed embryo transfer was seen in age category of ≥36 and ≤39 years (P = 0.018, Table 4 ).
| D ISCUSS I ON
To our knowledge, this is the first report from a single IVF center that has applied the freeze-all strategy to all patients and analyzed a large number of embryo transfers by patient's age category.
Before the advent of the vitrification technique, slow freezing had been mainly employed for the cryopreservation of embryos.
The post-thaw embryo survival rate with slow freezing at our IVF center, despite exceeding 90%, is more than 5% lower than that with vitrification. Even such small difference may cause a grave concern to patients who have a difficulty in collecting oocytes, such as low responders and women of advanced age. The dissemination of vitrification has improved post-thaw embryo survival rates to ≥99%, and these high survival rates are expected to overcome the risk of cryodamage.
The age of women seeking fertility treatment continues to increase yearly. At our IVF center, about 50% of women undergoing assisted reproductive technology (ART) treatment are 40 years or older. The increased age of women is associated with various challenges such as decreased number of oocytes retrieved, low pregnancy rates, and high miscarriage rates. In patients of advanced age, serum P4 and E2 levels per mature oocyte are higher, probably because of the prolonged duration and higher FSH usage in COS required for the collection of sufficient mature oocytes. Since high P4 levels have been shown to result in low pregnancy rates with fresh embryo transfer, the freeze-all strategy allows the separation of an embryo transfer cycle from an oocyte retrieval cycle in such patients.
The comparisons of serum P4 and E2 levels per mature oocyte on the day of hCG injection and the fertilization rates between TA B L E 2 Serum P4 and E2 levels per mature oocyte and Fertilization rates by age category (1) cycles in which oocytes were retrieved only for oocyte cryopreservation.
(2) cycles in which oocytes were repeatedly retrieved. (3) cycles in which oocytes were derived by delayed ICSI. Serum E2 and P4 levels were measured on the day of hCG injection. a Comparisons of serum E2 per mature oocyte between age categories were assessed using Steel-Dwass test. Significant differences were observed between any two age categories (all P < 0.001). b Comparisons of serum P4 per mature oocyte between age categories were assessed using Steel-Dwass test. Significant differences were observed between any two age categories (all P < 0.001, except for 40-42 vs 43≦: P < 0.05). c Comparisons of fertilization rates between age categories were assessed using Steel-Dwass test. d Significantly different from the fertilization rates in age≦30 and age 31-35 (P = 0.006 and 0.048, respectively). e Significantly different from the fertilization rates in age≦30 and age 31-35 (both P < 0.001). f Statistically significant difference (P < 0.05).
different age categories (Table 2) showed that both P4 and E2 levels were significantly increased and the fertilization rates were significantly decreased in patients of advanced age, so that it seemed serum P4 and E2 levels on the day of hCG injection had affected on embryo quality. Nevertheless, since there were no significant differences in comparison of fertilization rate by serum P4 levels (Table 3) , the decreases in fertilization rate shown in Table 2 were thought to be mainly caused by advancing age. There are reports that high serum E2 levels at oocyte retrieval compromised the quality of embryos derived from the oocytes and the resulting TA B L E 3 Pregnancy rates with fresh embryo transfer and frozen-thawed transfer by serum P4 level on the day of hCG injection 
2≦P4<5 5≦P4
No. of cycles (n) Serum E2 and P4 levels were measured on the day of hCG injection. a Comparisons of fertilization rates between serum P4 level groups were assessed using Steel-Dwass test. b Significantly different from the fertilization rates in 2≦P4<5 (Freeze all) and 5≦P4 (Freeze all) (both P = 0.006). c Significantly different from the fertilization rates in 2≦P4<5 (Freeze all) and 5≦P4 (Freeze all) (P = 0.005 and P = 0.001, respectively). d Comparisons of pregnancy rates between fresh embryo transfer and frozen-thawed embryo transfer by serum P4 level were assessed using Fisher's exact test. e Statistically significant difference (P < 0.05).
pregnancy rates [14] [15] [16] ; however, the compromised embryo quality may be attributed to the negative effects of P4 levels increased concomitantly with the increase in E2 levels on the endometrial environment before fresh embryo transfer, rather than the direct effects of E2 on embryo quality.
This study showed that the pregnancy rate with frozen-thawed embryo transfer was higher than that with fresh embryo transfer in patients aged 42 years or younger, suggesting that frozen-thawed embryo transfer provided the endometrial environment more suitable for embryo transfer by reversing the increased hormone levels in oocyte retrieval cycles and then readjusting the hormone levels in later embryo transfer cycles.
Thus, the freeze-all strategy that allowed the separation of embryo transfer cycles from oocyte retrieval cycles provided improved pregnancy rates in women aged 42 years and younger. If many mature oocytes can be collected with no concerns for adverse impacts on embryo transfer, the number of embryo transfers per oocyte retrieval should be increased, leading to the improvement in cumulative pregnancy rates.
In conclusion, the freeze-all strategy will surely become increasingly important, with an expected rise in the number of women of advanced age who seek fertility treatment. On the other hand, conventional fresh embryo transfer in the same cycle of COS is thought to have no advantage in consideration of the treatment-induced maternal hormonal environment during implantation.
The post-thaw embryo survival rates with slow freezing and vitrification and pregnancy rates with frozen-thawed embryos transfer and fresh embryos transfer, described above, were not results obtained from a comparative study as it was performed through long-term experience of clinical treatment. Therefore, the conditions of treatment procedures (eg, culture) were not completely identical among the cycles. Nevertheless, as we believe these differences had negligible impacts on the post-thaw embryo survival rates and pregnancy rates, statistical analyses on these results have been performed. It should be noted, however, that it is not only the difference between frozen-thawed embryos transfer and fresh embryos transfer that may affect the result of these analyses in view of this point.
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